Home

Novartis India Ltd Quarterly Result

Image

Novartis India Ltd

NSE: NOVARTIND

Net Profit - Last Quarter

₹ 20.41 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Novartis India Ltd for the Sep '24 is ₹ 97.43 crore as compare to the Jun '24 revenue of ₹ 102.7 crore. This represent the decline of -5.1314473%.
  • The ebitda of Novartis India Ltd for the Sep '24 is ₹ 28.29 crore as compare to the Jun '24 ebitda of ₹ 34.38 crore. This represent the decline of -17.713787%.
  • The net profit of Novartis India Ltd for the Sep '24 is ₹ 20.41 crore as compare to the Jun '24 net profit of ₹ 25.74 crore. This represent the decline of -20.707071%.

Results Analysis

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025865.9
14 Jan 2025852.3
13 Jan 2025836.9
10 Jan 2025879.6
09 Jan 2025914
08 Jan 2025913.4
07 Jan 2025904.35
06 Jan 2025901.6
03 Jan 2025922.8
02 Jan 2025899.8

Historical Revenue of Novartis India Ltd

No data available

* All values are in crore

Historical EBITDA of Novartis India Ltd

No data available

* All values are in crore

Historical Net Profit of Novartis India Ltd

No data available

* All values are in crore

Novartis India Ltd News Hub

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024. Powe

Read more

2024-09-28 00:00:00

Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 a

Read more

2024-10-25 00:00:00

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

2024-12-28 00:00:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Novartis India Ltd

What key financial metrics are included in Novartis India Ltd's quarterly results?

Key financial metrics in Novartis India Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Novartis India Ltd announce its quarterly results?

Novartis India Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Novartis India Ltd's quarterly performance impact its stock price?

Novartis India Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Novartis India Ltd's quarterly results on dividends?

The impact of Novartis India Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Novartis India Ltd's quarterly results?

Yes, Novartis India Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions